Aktieanalys

InDex Pharmaceuticals: Business Update - Redeye

{newsItem.title}

Redeye Publicerad: 11 May 2023 15:54

Watch the replay from InDex Pharmaceuticals' business update on May 9. The event featured the company's leadership team sharing insights and updates on the ongoing phase 3 CONCLUDE clinical program with the company's lead asset, cobitolimod. The event also featured a Q&A, among other things.

Länk till analysen i sin helhet: https://www.redeye.se/video/event-presentation/905259/index-pharmaceuticals-business-update-may-9-2023?utm_source=finwire&utm_medium=RSS

Nyheter om Flerie

Läses av andra just nu

Om aktien Flerie

Senaste nytt